Complex Information for Anesthesiologists Presented Quickly and Clearly

NMBA = neuromuscular-blocking agent; OR = odds ratio; TOF = train of four.

Infographic created by Jonathan P. Wanderer, Vanderbilt University School of Medicine, and James P. Rathmell, Massachusetts General Hospital/Harvard Medical School. Illustration by Annemarie Johnson, Vivo Visuals. Dr. Wanderer is funded by the Foundation for Anesthesia Education and Research, Rochester, Minnesota, and Anesthesia Quality Institute’s Mentored Research Training Grant – Health Services Research, Schaumburg, Illinois. Address correspondence to Dr. Wanderer: jon.wanderer@vanderbilt.edu.

1.
Naguib
M
,
Kopman
AF
,
Lien
CA
,
Hunter
JM
,
Lopez
A
,
Brull
SJ
:
A survey of current management of neuromuscular block in the United States and Europe.
Anesth Analg
2010
;
111
:
110
9
2.
Brull
SJ
,
Murphy
GS
:
Residual neuromuscular block: Lessons unlearned. Part II: Methods to reduce the risk of residual weakness.
Anesth Analg
2010
;
111
:
129
40
3.
Murphy
GS
,
Brull
SJ
:
Residual neuromuscular block: Lessons unlearned. Part I: Definitions, incidence, and adverse physiologic effects of residual neuromuscular block.
Anesth Analg
2010
;
111
:
120
8
4.
McLean
DJ
,
Diaz-Gil
D
,
Farhan
HN
,
Ladha
KS
,
Kurth
T
,
Eikermann
M
:
Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications.
Anesthesiology
2015
;
122
:
1201
13

Competing Interests

Dr. Wanderer is funded by the Foundation for Anesthesia Education and Research, Rochester, Minnesota, and Anesthesia Quality Institute’s Mentored Research Training Grant – Health Services Research, Schaumburg, Illinois.

free